News in English
Январь
2025
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31

Новости за 01.01.2025

Technology.inquirer.net 

Campus DEVCON Summit helps 700+ young minds shape tech’s future

LIPA, BATANGAS – Philippine tech developer community DEVCON recently held its biggest regional campus summit, Tech Nexus. Tech Nexus offered students a chance to learn cutting-edge technology topics, such as including quantum computing and artificial intelligence. READ: Viu hosts Campus Connect at NU and Arellano University As a result, DEVCON hopes to build the next

«The Times of India» (indiatimes.com) 

Woman tries to kill 21-year-old friend in Noida for refusing to marry her

A 21-year-old Noida youth, Dheeraj, was attacked by a woman named Priya after declining her marriage proposal. Dheeraj, currently treated at Yatharth Hospital, was drugged and assaulted in a car by Priya and her accomplices. Rabupura police have registered a case against Priya and her unidentified friends for attempted murder, with an ongoing investigation.

Economictimes.indiatimes.com 

Bumrah eclipses Ashwin's rating-point record in latest ICC rankings

Jasprit Bumrah surpassed Ravichandran Ashwin's all-time rating-point record by an Indian, reaching 907 in the ICC Test bowler rankings. His performance aided this feat during the Boxing Day Test. Additionally, Pat Cummins and Yashasvi Jaiswal saw significant rating improvements after their notable contributions in the same series.

Err.ee (en) 

What to expect in Estonia in 2025

Happy New Year! 2025 is finally here, but what can we expect? ERR News outlines some of the events and changes of the coming year.

Technology.inquirer.net 

US approves first-ever obstructive sleep apnea drug

On December 20, 2024, pharmaceutical company Eli Lilly announced that the FDA approved its first and only obstructive sleep apnea medication.  Zepbound or Tirzepatide is an injectable drug that the company designed as an obesity treatment.  READ: Scientists may have found the purpose of sleep The Food and Drug Administration, however, approved it for this